With the advent of effective medical therapies for melanoma, a pertinent question has arisen: When should we scan our patients?
In this podcast, our multidisciplinary experts, led by A/Prof Sydney Ch’ng, discuss the balance of whether we should be more aggressive in our pursuit of identifying potential metastases or exercise caution to avoid unnecessary scans, radiation exposure and patient anxiety. The discussion concludes with a case study to summarise key learnings.
This podcast is suitable for Medical Oncologists, Oncologists, Surgeons, GPs, Oncology Nurses and other healthcare professionals.
RESOURCES
Melanoma Risk Prediction Tools
SPEAKERS
A/Prof Sydney Ch’ng - Plastic & Reconstructive
Surgeon and Head & Neck Surgeon, Melanoma Institute Australia, Associate Professor of Surgery, The University of Sydney
A/Prof Alexander Menzies - Medical Oncologist,
Melanoma Institute Australia, Royal North Shore and Mater Hospitals | Associate Professor of Melanoma Medical Oncology, The University of Sydney
A/Prof Alexander van Akkooi - Associate Professor in
Melanoma Surgical Oncology, Melanoma Institute Australia and Royal Prince Alfred Hospital, The University of Sydney
Dr Edward Hsiao - Radiologist and Nuclear Medicine Specialist, Mater Imaging
Dr Kevin London - Nuclear Medicine Specialist, The Children’s Hospital at Westmead | Clinical Senior Lecturer, The University of Sydney
Please note that this podcast was accurate at the time of recording (September 2023) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
For more practice-changing education, visit our Melanoma Education Portal.
MIA’s Education Program is proudly supported through unrestricted educational grants from MSD, Bristol Myers Squibb and HEINE.
